adalimumab
abbvie
['crohn', 'adalimumab', 'ibd']
interesting study looking at lengthening interval for adalimumab in crohn s pts. outcome: non inferior compared to pts who had standard treatment. #ibd #ueg 
Associate Professor, Gastroenterologist - IBD, microbiome, Co-founder https://t.co/Xhgfwnb0dG (digital tool -  management of IBD and bowel preparation)